Jason N. Gorevic - Mar 3, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol: TDOC
Transactions as of: Mar 3, 2023
Transactions value $: -$571,078
Form type: 4
Date filed: 3/7/2023, 03:16 PM
Previous filing: Mar 3, 2023
Next filing: May 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Sale	-$571K	-22K	-3.52%	$25.91	603K	Mar 3, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Award	$0	+186K		$0.00	186K	Mar 3, 2023	Common Stock	186K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
F2	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3	One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.